Europe's Medical Device Makers Embrace AI Innovation
MWN-AI** Summary
European medical device manufacturers are increasingly integrating artificial intelligence (AI) into their operations, according to a new report by Information Services Group (ISG). This trend is driven by the need for healthcare resilience, evolving regulations, and technological advancements. The 2025 ISG Provider Lens® Medical Device Digital Services report reveals that European companies are modernizing regulatory practices, enhancing patient safety, and improving post-market surveillance through digital transformation.
As regulatory frameworks like the European Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) evolve, firms are automating compliance documentation and monitoring processes. ISG's director, Sven Geissler, noted that these innovations are yielding measurable benefits—companies are reducing costs and enhancing device performance.
Moreover, there is a growing emphasis on patient-centered care, with many device manufacturers expanding remote-care capabilities through telemedicine and connected tools. These technologies not only support the aging population but also enhance chronic disease management. Eastern European markets are emerging as players in this AI adoption, with firms investing in regional compliance and reporting systems.
The report highlights the adoption of generative AI (GenAI) for regulatory submissions and quality documentation, reducing manual efforts and improving accuracy. Advanced analytics and digital twins are being utilized for performance validation, while digital quality management systems dynamically track audit findings.
Collaboration between device makers and service providers is also accelerating innovation with co-innovation labs enhancing safety and regulatory outcomes. Noteworthy leaders in the market include Accenture, Cognizant, and HCLTech, which are recognized for their operational excellence across multiple quadrants.
Overall, as device manufacturers align compliance with innovation, they are navigating a complex landscape effectively, ultimately positioning themselves for greater operational stability and market access.
MWN-AI** Analysis
The European medical device market is undergoing a significant transformation fueled by the integration of artificial intelligence (AI) into its operational fabric. According to the latest ISG Provider Lens report, this drive toward digital transformation is catalyzed by aging populations, new regulatory frameworks, and the continuous improvement expectations from healthcare stakeholders. Medical device companies in Europe are not just optimizing their operations; they are also enhancing patient safety through advanced AI-enabled solutions.
As firms adopt AI for regulatory submissions and quality documentation, they experience reduced manual efforts and increased accuracy—all crucial for post-marketing surveillance. Companies that strategically combine compliance with innovation stand to gain operational stability and broader market access. With regulations such as the European Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) mandating rigorous standards, investing in compliant AI tools and cloud platforms becomes essential. Observations from ongoing deployments suggest that those who align their operational strategies with these compliance requirements are better positioned for long-term success.
The rise of telemedicine and connected monitoring tools underscores a shift toward patient-centered care, particularly beneficial for managing chronic conditions in aging populations. Companies expanding remote-care capabilities should focus on integrated patient engagement platforms to enhance feedback and compliance tracking.
Investors looking at the medical device sector should consider leading firms recognized by ISG, such as Accenture, Cognizant, and TCS, which showcase robust digital service capabilities. Emerging players like LTTS as a Rising Star demonstrate promising potential, indicating that innovative approaches in AI are driving competitive advantages.
To capitalize on this growth, stakeholders must prioritize AI-enhanced operational strategies that ensure compliance while unlocking value in evolving healthcare landscapes.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Healthcare resilience goals and regulatory frameworks accelerate adoption of AI-enabled medical technology solutions , ISG Provider Lens ® report says
European medical device companies are carrying out digital transformations to modernize regulatory operations, strengthen post-market surveillance and improve patient safety, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.
The 2025 ISG Provider Lens ® Medical Device Digital Services report for Europe finds that enterprises are using digital platforms and solutions to optimize their operations in response to aging populations, evolving regulation and rapid technological change. Among other changes, they are upgrading product quality and vigilance systems to meet the European Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) standards and automating regulatory documentation, compliance reporting and post-market monitoring.
“European medical device makers are realizing measurable results from digital transformation,” said Sven Geissler, director at ISG. “They are reducing costs and improving device performance while strengthening the return on their technology investments.”
Device companies are expanding remote-care capabilities as part of a broader shift toward patient-centered models. Telemedicine and connected monitoring tools help support aging populations and manage chronic diseases while meeting mandatory timelines. Integrated patient engagement platforms collect feedback and track adherence, improving oversight and responsiveness. Adoption of new technologies and approaches has been faster in Western Europe, but Eastern Europe’s medical device industry is emerging as companies invest in compliance operations, regional regulatory intelligence and multilingual hubs for post-market reporting.
Enterprises are adopting GenAI to support regulatory submissions, vigilance reporting and quality documentation, reducing manual effort and improving accuracy, the report says. They are also deploying digital twins and advanced analytics to validate device performance and predict potential component failures, improving device reliability and safety. Upgraded digital quality management systems track corrective actions and audit findings in real time, enabling faster regulatory responses and stronger compliance outcomes.
Many device makers in the region are collaborating with service providers on operations and preparing for new generations of technology. Co-innovation labs are accelerating usability testing and device validation, improving safety and audit outcomes. Outcome-based provider pricing models, which tie fees to results such as regulatory approvals and complaint resolution timelines, are gaining traction with clients.
“Enterprises that align compliance with innovation are achieving greater operational stability and market access,” said Sneha Jayanth, lead analyst, ISG Provider Lens Research, and lead author of the report. “Validated AI tools, compliance-ready cloud platforms and secure data pipelines are quickly becoming mandatory capabilities for medical device manufacturers.”
The report also explores other trends in Europe’s medical device industry, including the increasing adoption of digital-first quality management systems and the integration of sustainability goals into regulatory strategies.
For more insights into challenges relevant to medical device digital services in Europe, plus ISG’s advice for overcoming them, see the ISG Provider Lens ® Focal Points briefing here .
The 2025 ISG Provider Lens ® Medical Device Digital Services report for Europe evaluates the capabilities of 21 providers across three quadrants: Digital Engineering and Product Development, Regulatory Compliance, Strategy and Quality Assurance, and Post-Market Digital Enablement.
The report names Accenture, Cognizant, HCLTech, Infosys, TCS and Wipro as Leaders in three quadrants each. It names Capgemini as a Leader in two quadrants. Deloitte and LTTS are named as Leaders in one quadrant each.
In addition, LTTS is recognized as a Rising Star — a company with a “promising portfolio” and “high future potential” by ISG’s definition — in two quadrants. HARMAN is named as a Rising Star in one quadrant.
The 2025 ISG Provider Lens ® Medical Device Digital Services report for Europe is available to subscribers or for one-time purchase on this webpage .
About ISG Provider Lens ® Research
The ISG Provider Lens ® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage .
About ISG
ISG (Nasdaq: III ) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028710261/en/
Press Contacts:
Laura Hupprich, ISG
+1 203 517 3100
laura.hupprich@isg-one.com
Philipp Jaensch, ISG
+49 151 730 365 76
philipp.jaensch@isg-one.com
FAQ**
How is Information Services Group Inc. III predicting the impact of AI-enabled technology on regulatory compliance for European medical device companies?
What role does Information Services Group Inc. III believe digital transformation plays in enhancing patient safety and device performance within the medical device industry?
How is the collaboration between medical device makers and service providers, highlighted by Information Services Group Inc. III, reshaping operational strategies in the current regulatory environment?
In what ways does Information Services Group Inc. III anticipate that integrating sustainability goals with regulatory strategies will affect the future of digital services in the European medical device sector?
**MWN-AI FAQ is based on asking OpenAI questions about Information Services Group Inc. (NASDAQ: III).
NASDAQ: III
III Trading
-1.85% G/L:
$4.2107 Last:
41,329 Volume:
$4.17 Open:
